JavaScript is disabled for your browser. Some features of this site may not work without it.
Please be advised that the site will be down for maintenance on Sunday, September 1, 2024, from 08:00 to 18:00, and again on Monday, September 2, 2024, from 08:00 to 09:00. We apologize for any inconvenience this may cause.
Inclusivity and diversity : integrating international perspectives on stem cell challenges and potential
Fears, Robin; Akutsu, Hidenori; Alentajan-Aleta, Lara Theresa; Caicedo, Andres; De Carvalho, Antonio Carlos Campos; Colic, Miodrag; Cornish, Jillian; Cossu, Giulio; Debre, Patrice; Dierckxsens, Geoffrey; El-Badri, Nagwa; Griffin, George; Hsieh, Patrick Chingo-Ho; Inamdar, Maneesha S.; Kumar, Pradeep; Abraham, Consuelo Macias; Maciulaitis, Romaldas; Mahtab, Mamun Al; O’Brien, Fergal J.; Pepper, Michael Sean; Ter Meulen, Volker
Regenerative medicine has great potential. The pace of scientific advance is exciting and the medical opportunities for regeneration and
repair may be transformative. However, concerns continue to grow, relating to problems caused both by unscrupulous private clinics offering unregulated therapies based on little or no evidence and by premature regulatory approval on the basis of insufficient scientific
rationale and clinical evidence. An initiative by the InterAcademy Partnership convened experts worldwide to identify opportunities
and challenges, with a focus on stem cells. This was designed to be inclusive and consensus outputs reflected the diversity of the global
research population. Among issues addressed for supporting research and innovation while protecting patients were ethical assessment;
pre-clinical and clinical research; regulatory authorization and medicines access; and engagement with patients, policy makers, and the
public. The InterAcademy Partnership (IAP) identified options for action for sharing good practice and building collaboration within the
scientific community and with other stakeholders worldwide.